News

The FDA has added Lassa fever, chikungunya virus disease, rabies, and cryptococcal meningitis to the tropical disease Priority Review Voucher Program.

Health care providers, especially those practicing in the southern United States, should consider angiostrongyliasis in patients with eosinophilic meningitis.

A new review examines previous studies and concludes that healthcare professionals could benefit from sensitivity training when dealing with patients who have HAIs.

The incidence of Neisseria meningitidis serogroup W is rising in Georgia.

The results are significant given the ongoing debate regarding the role of contact precautions for the gram-positive bacteria.

We’ve rounded up the Salmonella outbreaks that have been declared by the US Centers for Disease Prevention and Control so far this summer.

Closing treatment gaps is critical to ending the HIV epidemic in the United States.

A new study reveals that the quadrivalent HPV catch-up vaccine was most effective against cancer risk in women who received the first dose between the ages of 14 and 20 years.

There is a new treatment for this old disease, so why are we still worried?

The NIH has begun a phase 1 trial assessing the safety of rZIKV/D4Δ30-713, a Zika virus vaccine.

Over 400 individuals have been infected with Cyclospora across 15 states in an outbreak linked to McDonald’s salads.

A recent molecular study has confirmed the causative agent involved in a large epidemic of Rocky Mountain spotted fever in humans and dogs in Mexicali, in Baja California, Mexico.

We’re rounded up a list of recalls issued by the US Food and Drug Administration (FDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A total of 107 cases of measles has been reported thus far this year in the United States and the District of Columbia, underscoring the importance of vaccination.

New research from Johns Hopkins reveals that 2 genes, CMPK2 and BCLG, are selectively activated in the presence of type 1 interferon.

While communicable HFMD is more prevalent in children, there has been an increase in individuals of all ages, making awareness regarding recognition, diagnosing, and treatment imperative.

Candidemia is a significant risk factor for C difficile infection in hospital patients.

Use of ibalizumab in combination with other HIV treatment could be an effective option for adults with advanced drug-resistant HIV.

A phase 3 trial has met its primary endpoint, showing a similar efficacy of a once-a-month injectable 2DR of cabotegravir and rilpivirine compared to daily, oral 3DR.

Since its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.

A 2-week old Ebola outbreak in the DRC has already surpassed the previous outbreak

The results of a study published by JAMA Internal Medicine are a call to action for cities facing homelessness crises.

A new report from researchers at the Centers for Disease Control and Prevention details the investigational use of a drug to treat Chagas disease now available commercially in the United States.

The CDC now recommends that men who have been exposed to Zika use condoms or abstain from sex for 3 months to prevent sexual transmission of Zika.

The PDUFA action date has been set for February 13, 2019.

As health care services move into the outpatient setting, is infection control being overlooked?

Several outbreaks of mumps in university settings throughout Indiana in 2016 highlight a need for standardized immunization record collection and a third MMR vaccination dose for individuals at increased risk of infection.

Small studies show good outcomes for previously uninfected recipients who receive kidneys from donors infected with hepatitis.

We’re rounded up a list of recalls issued by the US Food and Drug Administration (FDA) from this past week.